Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ (CTTNKTL-Ⅲ/Ⅳ)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2013 by Zhengzhou University
The Second Hospital of Shanxi Medical University
Cancer hospital of shanxi province
Wuhan University
Wuhan TongJi Hospital
Wuhan Union Hospital, China
Qingdao University
Cancer Hospital of Guizhou Province
Central Hospital Of Xinxiang
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Information provided by (Responsible Party):
Mingzhi Zhang, Zhengzhou University Identifier:
First received: November 29, 2011
Last updated: September 19, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2019
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)